90 related articles for article (PubMed ID: 6197664)
1. Allogenic modification of rat sarcoma cells in vitro by staphylococcal exotoxin.
Hlavayová E; Svec J
Neoplasma; 1983; 30(6):667-80. PubMed ID: 6197664
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of Staphylococcus aureus on the growth of rat sarcoma].
Dlugovitzky DG; Molteni OA
Rev Argent Microbiol; 1988; 20(3):125-35. PubMed ID: 3231711
[TBL] [Abstract][Full Text] [Related]
3. Secretion of IL-6, IL-8 and G-CSF by human endothelial cells in vitro in response to Staphylococcus aureus and staphylococcal exotoxins.
Söderquist B; Källman J; Holmberg H; Vikerfors T; Kihlström E
APMIS; 1998 Dec; 106(12):1157-64. PubMed ID: 10052724
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenetic study of tumor growth in inbred rats].
Urizar LA; Ballina JC; Amerio N; Morini JC; Rabasa SL
Medicina (B Aires); 1982; 42(4):403-8. PubMed ID: 15171022
[No Abstract] [Full Text] [Related]
7. The "in vivo" effect of protein A on tumor growth.
Dima S; Moraru I
Neoplasma; 1986; 33(6):679-84. PubMed ID: 3808122
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
9. [Macrophage adherence inhibition test (MAI) in Wistar rats bearing Jensen tumors. I. MAI after incubation with tumor-associated antigens].
Neumeister B; Hambsch K; Storch H
Arch Geschwulstforsch; 1983; 53(6):521-8. PubMed ID: 6200084
[TBL] [Abstract][Full Text] [Related]
10. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity expressed by cells active against established tumors in vivo.
Tuttle RL; Knick VC; Stopford CR; Weck CJ; Wolberg G
Cancer Res; 1981 Jul; 41(7):2633-9. PubMed ID: 6788359
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and physical characterizations of tumor-associated fetal antigens.
Evans DL; Parker DV; Frank MK
Cancer Res; 1979 Jun; 39(6 Pt 1):2006-15. PubMed ID: 87258
[No Abstract] [Full Text] [Related]
13. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
15. The role of target antigens coded by subregions of the mouse H-2 complex in the nature of growth of sarcoma I tumor allograft.
Vidrnová M; Nouza K
Neoplasma; 1983; 30(5):527-32. PubMed ID: 6606786
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterizations of tumor-associated fetal antigens.
Evans DL; Frank MK; McKinnon KP; Cerrone M
Cancer Res; 1979 Jun; 39(6 Pt 1):2016-25. PubMed ID: 87259
[No Abstract] [Full Text] [Related]
17. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
Ryzewska AG; Rybicka M; Kania A; Dabrowski M
Neoplasma; 1980; 27(5):533-42. PubMed ID: 7231610
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.
Thomas SM; Zeng Q; Epperly MW; Gooding WE; Pastan I; Wang QC; Greenberger J; Grandis JR
Clin Cancer Res; 2004 Oct; 10(20):7079-87. PubMed ID: 15501988
[TBL] [Abstract][Full Text] [Related]
19. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
20. Immunology of sarcomas.
Bernstein ID; Wright PW
Natl Cancer Inst Monogr; 1981 Apr; (56):177-82. PubMed ID: 7029288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
